The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Effects of D-cycloserine on extinction of conditioned freezing.
Abstract
The present study tested the prediction that D-cycloserine (DCS), a partial N-methyl-D-aspartate agonist, would facilitate extinction of conditioned freezing in male Sprague-Dawley rats. Rats received 5 light-shock pairings (conditioning). The following day, rats received 6 light-alone presentations (extinction training). Twenty-four hours later, rats received 1 light-alone presentation (test). Subcutaneous DCS injection before or after extinction training significantly enhanced extinction, and the dose-response curve for this effect was linear. Increasing the delay of DCS administration after extinction training led to a linear decrease in the facilitatory effect. The effect of systemic administration was replicated by intra-basolateral amygdala infusion. These results suggest that DCS facilitates extinction of conditioned freezing by acting on consolidation processes partly mediated by the basolateral amygdala.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“administration of the NMDAR partial agonist D-cycloserine (DCS) enhances the acquisition of the extinction memory”
From Retrieval-Dependent Mechanisms Affecting Emotional Memory Persistence: Reconsolidation, Extinction, and the Space in Between (2020) · cites this paper as Ledgerwood et al., 2003
In the citing paper
“with no effect when administered after re-exposure in rodents (Ledgerwood et al., 2003; Lee et al., 2006a)”
From Retrieval-Dependent Mechanisms Affecting Emotional Memory Persistence: Reconsolidation, Extinction, and the Space in Between (2020) · cites this paper as Ledgerwood et al., 2003
In the citing paper
“Preclinical research has demonstrated that DCS facilitates extinction learning and memory in rodent models (Davis et al, 2006; Ledgerwood et al, 2003; Walker et al, 2002).”
From D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial (2014) · cites this paper as Ledgerwood et al, 2003
In the citing paper
“We chose weekly dosing, administered 90 min before exposure sessions, as this regimen has been effective in multiple animal and human fear extinction studies (Ledgerwood et al, 2003; Ressler et al, 2004; Walker et al, 2002)”
From D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial (2014) · cites this paper as Ledgerwood et al, 2003
In the citing paper
“administration of D-cycloserine (DCS), a partial agonist of the NMDA receptor involved in long-term potentiation (a cellular model of learning), facilitates extinction (e.g., Walker, Ressler, Lu, & Davis, 2002; Ledgerwood, Richardson, & Cranney, 2003).”
From D-cycloserine facilitates context-specific fear extinction learning (2008) · cites this paper as Ledgerwood, Richardson, & Cranney, 2003
In the citing paper
“Our results are generally in agreement with the results of Walker et al (2002) and Ledgerwood et al (2003), in which DCS systemic administration enhanced the extinction of conditioned fear.”
From Effects of Single Prolonged Stress and D-Cycloserine on Contextual Fear Extinction and Hippocampal NMDA Receptor Expression in a Rat Model of PTSD (2008) · cites this paper as Ledgerwood et al (2003)
In the citing paper
“Likewise, though the molecular mechanism of contextual fear extinction remains to be precisely determined, the N-methyl-D-aspartate (NMDA) receptor appears to play a critical role in fear extinction (Falls et al, 1992;Ledgerwood et al, 2003Ledgerwood et al, , 2004Ledgerwood et al, , 2005;;Rodrigues et al, 2001;Santini et al, 2001;Walker et al, 2002).”
From Effects of Single Prolonged Stress and D-Cycloserine on Contextual Fear Extinction and Hippocampal NMDA Receptor Expression in a Rat Model of PTSD (2008) · cites this paper as Ledgerwood et al, 2003
In the citing paper
“The DCS dose (15 mg/kg per rat) was chosen on the basis of the results of other behavioral studies (Ledgerwood et al, 2003(Ledgerwood et al, , 2005;;Walker et al, 2002).”
From Effects of Single Prolonged Stress and D-Cycloserine on Contextual Fear Extinction and Hippocampal NMDA Receptor Expression in a Rat Model of PTSD (2008) · cites this paper as Ledgerwood et al, 2003
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Neurobiology of Pavlovian fear conditioning
Maren, S. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.897 · Cited by 1,543
Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain
Monaghan, D., & Cotman, C. W. (1985) · Journal of Neuroscience · doi:10.1523/jneurosci.05-11-02909.1985 · Cited by 1,279
NMDA receptors - their role in long-term potentiation
Collingridge, G. L., & Bliss, T. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90175-5 · Cited by 1,178
Aguado Aguilar, L. (2001) · PubMed · Cited by 1,072
Neural organization of the defensive behavior system responsible for fear
Fanselow, M. S. (1994) · Psychonomic Bulletin & Review · doi:10.3758/bf03210947 · Cited by 1,000
From normal fear to pathological anxiety.
Rosen, J. B., & Schulkin, J. A. (1998) · Psychological Review · doi:10.1037/0033-295x.105.2.325 · Cited by 914
A perceptual-defensive-recuperative model of fear and pain
Bolles, R. C., & Fanselow, M. S. (1980) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0000491x · Cited by 840
Miserendino, M. J. D., Sananes, C. B., Melia, K. R., & Davis, M. (1990) · Nature · doi:10.1038/345716a0 · Cited by 824
Research works printed but not linked: 1
- Bouton, 1991, A contextual analysis of fear extinction., 435
Cited by
Sorted by citations
Items 301–388 of 388
Combining d-cycloserine and exposure-based CBT for the anxiety disorders.
Deveney, C. M., McHugh, R. K., Tolin, D. F., Pollack, M. H., & Otto, M. W. (2009) · Cited by 9
Sierra, R. O., Nítola, L. P., Duran, J. M., Prieto, D. R., León, L. A., & Cárdenas, F. P. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.08.021 · Cited by 9
Golisch, A., Heba, S., Glaubitz, B., Tegenthoff, M., & Lissek, S. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00034 · Cited by 6
Enhancing Fear Extinction: Pharmacological Approaches
Ponomareva, O. Y., Fenster, R. J., & Ressler, K. J. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_443 · Cited by 7
Leslie, J. C., & Norwood, K. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.02.002 · Cited by 9
Asfestani, M. A., Braganza, E. M., Schwidetzky, J., Santiago, J. C. P., Soekadar, S. R., Jan Born, A., & Feld, G. B. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0139-0 · Cited by 8
Neural systems involved in fear and anxiety based on the fear-potentiated startle test
Davis, M. (2007) · Elsevier eBooks · doi:10.1016/b978-012372540-0/50013-3 · Cited by 6
Shen, Y.-F., Chou, Y.-H., Yang, Y.-L., & Lu, K. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2244-1 · Cited by 7
Diminich, E. D., Dickerson, F., Bello, I., Cather, C., Kingdon, D., Rouhakhtar, P. R., Hart, K. L., Li, C., Troxel, A. B., & GOFF, D. C. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.06.015 · Cited by 7
Preclinical behavioral and pharmacological treatments for enhancing fear extinction in adolescence
Wall, E. K., Virakorn, E. A., Baker, K., Cohen, E. M., & Richardson, R. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106090 · Cited by 6
Self-citationBerberine Facilitates Extinction and Prevents the Return of Fear
Huang, S., Zhou, Y., Wu, F., Shi, C., He, Y., Chen, L., Yang, C., & Luo, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.748995 · Cited by 6
Stylianakis, A. A., Baker, K., & Richardson, R. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.822709 · Cited by 6
Self-citationWu, I.-T., Tang, T., Ko, M.-C., Chiu, C.-Y., & Lu, K. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4042-7 · Cited by 6
Molecular mechanisms of D-cycloserine in facilitating fear extinction: insights from RNAseq
Malan‐Müller, S., Fairbairn, L., Daniels, W. M. U., Dashti, M. J. S., Oakeley, E. J., Altorfer, M., Kidd, M., Seedat, S., Gamieldien, J., & Hemmings, S. M. J. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9727-4 · Cited by 5
A New Appraisal of Combined Treatments for PTSD in the Era of Psychotherapy Adjunctive Medications
Sheerin, C. M., Seim, R. W., & Spates, C. R. (2011) · Journal of Contemporary Psychotherapy · doi:10.1007/s10879-011-9195-z · Cited by 6
Faucher, C. R., Doherty, R. A., Philip, N. S., Harle, A. S. M., Cole, J. J. E., & Wout‐Frank, M. V. ‘. (2021) · Behavioral Neuroscience · doi:10.1037/bne0000487 · Cited by 7
Neuroanatomical Structures Underlying the Extinction of Drug-Seeking Behavior
Cleva, R. M., & Gass, J. T. (2013) · The Open Addiction Journal · doi:10.2174/18749410010030200063 · Cited by 6
Malan‐Müller, S., Fairbairn, L., Hart, S. A., Daniels, W. M. U., Dashti, M. J. S., Kidd, M., Seedat, S., Gamieldien, J., & Hemmings, S. M. J. (2017) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000176 · Cited by 6
Post-extinction L-DOPA administration to reduce the return of fear in humansPreprint
Gerlicher, A. M. V., Ilhan-Bayrakcı, M., Tüscher, O., & Kalisch, R. (2022) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/rhnsa · Cited by 4
Mendis, K., Gnanapragasam, M. A., Keerthirathne, D. H. G. A. N., Madushani, L. A. N., Piyasekara, G. M. T. M., Senanayake, S., Bandara, C., Abeytunga, T. U., Gunaratna, T. A. N. R., & Jayakody, T. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100794 · Cited by 6
Sepahvand, T., Nazari, N., Qin, T., Rajani, V., & Yuan, Q. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2309986120 · Cited by 7
Chapter 2.3 Extinction of fear: From animal studies to clinical interventions
Myers, K. M., & Davis, M. E. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00004-5 · Cited by 5
Enhancing Exposure Therapy for PTSD Using d-Cycloserine
Burton, M. S., Youngner, C., McCarthy, A. J., Rothbaum, A. O., & ROTHBAUM, B. O. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7522-5_18 · Cited by 5
Effects of linalool on extinction of mouse operant behaviour
Shaw, D., Norwood, K., Kennedy, P. J., & Leslie, J. C. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000511 · Cited by 5
Update on the Assessment, Diagnosis, and Treatment of Individuals with Social Anxiety Disorder
Delong, H., & Pollack, M. H. (2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.4.foc431 · Cited by 5
Lissek, S., Klass, A., & Tegenthoff, M. (2022) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2022.107672 · Cited by 4
Leslie, J. C., Sharp, K., Quigley, L., Carson, A., McGovern, S. F. J., & Shaw, D. (2007) · European Journal of Behavior Analysis · doi:10.1080/15021149.2007.11434287 · Cited by 4
Wood, M. A. (2010) · Apollo (University of Cambridge) · doi:10.17863/cam.16464 · Cited by 3
Kantak, K. M., Gauthier, J. M., Mathieson, E., Knyazhanskaya, E. E., Rodriguez-Echemendia, P., & Man, H. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112839 · Cited by 3
The Role of Mitogen-Activated Protein Kinase in Treatment Strategies for Fear and Drug Addiction
Mary, R., Andrew, J., & Hyun, J. (2012) · InTech eBooks · doi:10.5772/36756 · Cited by 2
NeuralBasis of Human Fear Learning
Dunsmoor, J. E., & LaBar, K. S. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511843716.023 · Cited by 3
Animal Models of Psychiatric Disorders: Behaviour Analysis Perspectives
Leslie, J. C. (2011) · European Journal of Behavior Analysis · doi:10.1080/15021149.2011.11434353 · Cited by 3
d-cycloserine augmentation of exposure therapy: Review and new directions
Davis, M., Witcraft, S. M., Smits, J. A. J., Dowd, S. M., Pollack, M. H., Rosenfield, D., Otto, M. W., & Hofmann, S. G. (2016) · Radboud Repository (Radboud University) · Cited by 3
Arman, S., Soheilimehr, A., & Maracy, M. R. (2017) · Advanced Biomedical Research · doi:10.4103/2277-9175.200786 · Cited by 5
Lee, J. L. C., & Everitt, B. J. (2007) · Research and perspectives in neurosciences · doi:10.1007/978-3-540-45702-2_6 · Cited by 3
Sheerin, C. M. (2013) · ScholarWorks - WMU (Western Michigan University) · Cited by 3
Novel approaches in treatment of pediatric anxiety
Park, J. M., & Geller, D. A. (2014) · F1000Prime Reports · doi:10.12703/p6-30 · Cited by 2
“DCS is an NMDA partial agonist that has been shown to enhance fear extinction learning in both animals and humans [51-53].”
BackgroundEffect of blast exposure on sensorimotor gating and fear memory
Vaughn, M. N., Geyer, M. A., Powell, S. B., Ng, L. J., Risbrough, V. B., & Halberstadt, A. L. (2025) · Physiology & Behavior · doi:10.1016/j.physbeh.2025.115029 · Cited by 2
Advances in Pharmacotherapy for Pediatric Anxiety Disorders
Rynn, M. A., Puliafico, A. C., Heleniak, C. M., Rikhi, P., Ghalib, K., & Vidair, H. B. (2011) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.9.3.foc299 · Cited by 2
Augmentation of Psychotherapy with D-Cycloserine in Patients with Anxiety Disorders
Lautenbacher, L. M., Pyrkosch, L., Mascarell-Maricic, L., & Ströhle, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_446 · Cited by 2
Computational modeling design of novel NMDAR agonist for the treatment of Schizophrenia
Manica, A. K., Daud, M., Faloyo, M. O., Afuape, A. R., Adekunle, A. M., Adekola, A. A., Lawal, I. A., Salawu, M. A., Muritala, J. A., Muraina, R. O., et al. (2025) · Neurogenetics · doi:10.1007/s10048-024-00796-2 · Cited by 2
Both, S., Veen, R. J. B. V., Brom, M., & Weijenborg, P. T. M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05457-4 · Cited by 2
Combined use of behavioral therapy and partial NMDA agonist to treat anxiety disorders
Stein, D. J. (2006) · Current Psychiatry Reports · doi:10.1007/s11920-006-0060-9 · Cited by 2
Psychopharmacology of Pediatric Anxiety Disorders
Mohatt, J. W., Keller, A. E., & Walkup, J. T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6599-7_14 · Cited by 2
Reaktionen auf schwere Belastungen und Anpassungsstörungen
Paulzen, M., & Gründer, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_80 · Cited by 2
Combined Treatment With CBT and Psychopharmacology
Lee, J., Hearon, B. A., & Otto, M. W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803457-6.00006-4 · Cited by 2
Graham, B. M., & Richardson, R. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5032-3 · Cited by 2
Self-citationPharmacological assistance for psychotherapy
Lochtenberg, J., Kirshenbaum, A. P., & Johnson, M. W. (2021) · Emerging Trends in Drugs Addictions and Health · doi:10.1016/j.etdah.2021.100017 · Cited by 2
An Evaluation of the Effects of D-Cycloserine on Operant Learning and Response Recovery
Martín, C. S., Alfaro, F., Bustamante, J., Laborda, M. A., Mallea, J., & Míguez, G. (2022) · Psykhe (Santiago) · doi:10.7764/psykhe.2021.33531 · Cited by 2
Augmentation of psychotherapy with d-cycloserine for anxiety disorders
Ipser, J., Sander, C., Seifan, A., & Stein, D. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007803 · Cited by 2
Fear Not: Neurobiological Mechanisms of Fear and Anxiety
Klumpers, F. (2007) · Utrecht University Repository (Utrecht University) · Cited by 2
Vorstenbosch, V., Newman, L., & Antony, M. M. (2013) · Wiley eBooks · doi:10.1002/9781118528563.wbcbt03 · Cited by 3
Essmat, N., Boldizsár, I., Chalabiani, Y., Varga, B. T., Abbood, S. K., Kirchlechner-Farkas, J. M., Király, K. P., Miklya, I., Gyertyán, I., Tábi, T., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110526 · Cited by 1
The Role of NMDA Receptors in Extinction of Cocaine Self-Administration
Hafenbreidel, M. (2013) · UWM Digital Commons (University of Wisconsin–Milwaukee) · Cited by 1
D-Cycloserine Augmentation of Cognitive-Behavioral Therapy for the Treatment of Anxiety Disorders
Janicak, P. G., Dattilo, N. C., Manos, R. C., Storch, E. A., & Goddard, A. W. (2011) · Psychopharm Review · doi:10.1097/01.psyphr.0000399653.06660.fa · Cited by 1
Cognitive Behavioral Therapy for Anxiety Disorders
Wieman, S. T., Kind, S., & Baker, A. W. (2019) · Current clinical psychiatry · doi:10.1007/978-3-030-30687-8_12 · Cited by 2
McGaugh, J. L., & Roozendaal, B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21092-4 · Cited by 1
Understanding Human Fear Extinction: Insights from Psychophysiology
Woodford, J., Riser, M., & Norrholm, S. D. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_435 · Cited by 1
Pharmacological enhancement of learning in exposure therapy
Ressler, K. J., Davis, M., & ROTHBAUM, B. O. (2007) · Elsevier eBooks · doi:10.1016/b978-012587421-2/50016-8 · Cited by 1
Translating Across Circuits and Genetics Toward Progress in Fear- and Anxiety-Related Disorders
Ressler, K. J. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.19205 · Cited by 1
Pharmacology of Fear Extinction
Davis, M., & Myers, K. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.00758-0 · Cited by 1
Malan‐Müller, S. (2014) · SUNScholar (Stellenbosch University) · Cited by 1
Manwell, L. A. (2013) · The Atrium (University of Guelph) · Cited by 1
Guastella, A. J., & Alvares, G. A. (2012) · Wiley eBooks · doi:10.1002/9781119945901.ch5 · Cited by 1
Campbell‐Sills, L., & Stein, M. B. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544392.036
Plasticity of fear memory: a search for relapse prevention
Effting, M. (2011) · UvA-DARE (University of Amsterdam)
Aupperle, R. L. (2009) · KU ScholarWorks (The University of Kansas)
An Examination of the Extended Effec ts of D- Cycloserine Treatment on Fear Extinction in Rats
Hall, S., & Kyek, R. T. (2009)
Predator-Based Fear Conditioning: A Novel Approach to the Study of the Neurobiology of Memory
Halonen, J. D. (2012) · Digital Commons - University of South Florida (University of South Florida)
cortexcircuits for fear and addiction overlap in prefrontal
Peters, J., Kalivas, P. W., & Quirk, G. J. (2009)
Neural mechanisms underlying extinction of emotional memory
Yamada, K., & Ichitani, Y. (2008) · Japanese Journal of Physiological Psychology and Psychophysiology · doi:10.5674/jjppp1983.26.27
Pittner, K., Kadosh, K. C., & Lau, J. Y. F. (2016) · doi:10.1002/9781118650813.ch18
Extinction, erasure, and the recovery of fear memories
Golkar, A. (2013)
Cortisol and stress modulation of fear memory reconsolidation
Drexler, S. M. (2016)
Whiteman, J. D. (2017) · Memorial University Research Repository (Memorial University)
Stovezky, Y. R., Gershkovich, M., Kayser, R. R., & Simpson, H. B. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108164313.020
Novaes, L. S. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2019.tde-18022019-144217
LincRNAs involved in DCS-induced fear extinction: Shedding light on the transcriptomic dark matterPreprint
Malan‐Müller, S., de Souza, V. B. C., Daniels, W. M. U., Seedat, S., Robinson, M. D., & Hemmings, S. M. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/834242
Animal Models in Anxiety Research
Perumal, M. B., & Sah, P. (2021) · Cambridge University Press eBooks · doi:10.1017/9781139087469.013
Augmentation of Psychotherapy with D-Cycloserine in Patients with Anxiety Disorders
Lautenbacher, L. M., Pyrkosch, L., Mascarell-Maricic, L., & Ströhle, A. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_446-1
Arden, J. (2015) · Wiley eBooks · doi:10.1002/9781119171683.refs
Quirk, G. J., & Sotres-Bayón, F. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.5699957.7599059
(2014) · Elsevier eBooks · doi:10.1016/b978-0-12-420071-5.16001-6
Woodruff‐Borden, J., Lee, A. M., & Gramszlo, C. (2018) · Wiley eBooks · doi:10.1002/9781394258970.ch9
Influence of aversive cue detection sensitivity on extinction in adult male ratsPreprint
Cahill, E., Sherman, E. R., Jollans, J., Deiana, S., & Hengerer, B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.30.591853
Gerami, S.-S., Ebrahimi-Ghiri, M., Zarrindast, M. R., & Khakpai, F. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.03.012
Role of the Amygdala in the Complex Relationship Between Sleep and Anxiety
Grzybowski, F., Kaczmarski, P., Strzelecki, D., Wysokiński, A., Białasiewicz, P., & Gabryelska, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177814
Fujiwara, H., Goto, J.-I., Fujii, S., & Yamazaki, Y. (2026) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2026.108222
Metadata
- Authors
- Ledgerwood, L., Richardson, R., & Cranney, J.
- Affiliations
- UNSW Sydney (AU)
- Venue
- Behavioral Neuroscience
- Published
- 2003
- Volume
- 117
- Issue
- 2
- Pages
- 341-349
- ISSN
- 0735-7044 (ISSN-L)
- 1939-0084
- OpenAlex
- W2129939370
- Cited by
- 388
- References
- 46
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 4 · 2023: 3 · 2022: 9 · 2021: 11 · 2020: 9 · 2019: 12 · 2018: 16 · 2017: 19 · 2016: 10 · 2015: 16 · 2014: 18 · 2013: 28 · 2012: 25
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Behavioral Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- D-cycloserine, extinction, conditioned freezing, NMDA receptor agonist, basolateral amygdala, memory consolidation, fear extinction, dose-response relationship
- MeSH terms
- Amygdala, Analysis of Variance, Animals, Brain Mapping, Conditioning, Psychological, Cycloserine, Dose-Response Relationship, Drug, Drug Administration Routes, Extinction, Psychological, Male, Reflex, Startle, Time Factors, Rats, Sprague-Dawley, Excitatory Amino Acid Agonists, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
